Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: The prognostic value of 18F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients

Fig. 2

Compared of two neuroblastoma patients with different AUC-CSH index and metabolic parameters. a 1-year-old girl with INSS 4 stage neuroblastoma had SUVmax of 3.5, MTVtotal of 196.23, TLGtotal of 272.08, and a lower AUC-CSHtotal of 0.387. The patient was disease progression at 3.6 months and dead at 6.2 months, after 18F-FDG PET/CT examination. b 1-year-old boy with INSS 3 stage neuroblastoma had SUVmax of 4.17, MTVtotal of 243.44, TLGtotal of 555.22, and a higher AUC-CSHtotal of 0.542. The patient was disease free at 32.5 months after 18F-FDG PET/CT examination

Back to article page